OC

OKG Capital

Description

OKG Capital

Investor Profile

OKG Capital has made 7 investments, with 4 in the past 12 months and 14% as lead.

Stage Focus

  • Seed (29%)
  • Series Unknown (29%)
  • Series A (29%)
  • Pre Seed (14%)

Country Focus

  • United States (43%)
  • United Kingdom (43%)
  • Germany (14%)

Industry Focus

  • Health Care
  • Medical
  • Software
  • Biotechnology
  • Health Diagnostics
  • Pharmaceutical
  • Therapeutics
  • Information Technology
  • Machine Learning
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does OKG Capital frequently co-invest with?

VB
North America, Georgia, United States, Germany
Co-Investments: 1
Co-Investments: 1
Werth Ventures
North America, Connecticut, United States, Woodbridge
Co-Investments: 1
A
Europe, Bayern, Germany, Munich
Co-Investments: 1
Connecticut Innovations
North America, Connecticut, United States, Rocky Hill
Co-Investments: 1
KHP Ventures
Europe, England, United Kingdom, London
Co-Investments: 2
Angel Investor Forum
North America, Connecticut, United States, Bristol
Co-Investments: 1
TR
North America, Connecticut, United States, Stamford
Co-Investments: 1
Macmillan Cancer Support
Europe, England, United Kingdom, London
Co-Investments: 2
Xcellerant Ventures
North America, Arizona, United States, Scottsdale
Co-Investments: 1

Which angels does OKG Capital often collaborate with?

NW
Europe, England, United Kingdom, London
Shared Deals: 1
OD
Europe, Hamburg, Germany, Hamburg
Shared Deals: 1
CB
Europe, Hamburg, Germany, Hamburg
Shared Deals: 1
AC
Europe, Berlin, Germany, Berlin
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by OKG Capital?

OxCan

Oxford, Oxfordshire, United Kingdom

OxCan is a startup that uses machine learning and liquid biopsy for early lung cancer detection.

BiotechnologyHealth CareHealth Diagnostics
Series AJan 9, 2025
Amount Raised: $11,000,000
52 North Health

Cambridge, Cambridgeshire, United Kingdom

52 North Health is developing a fully-integrated clinical, AI-driven medical device-based system called NeutroCheck for people with cancer.

Artificial Intelligence (AI)Health CareMedical
Series UnknownDec 3, 2024
Amount Raised: $6,000,000
iFast Diagnostics

Northampton, Northamptonshire, United Kingdom

iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial resistance.

Health Care
SeedNov 4, 2024
Amount Raised: $6,477,154
DeepLook Medical

New Haven, Connecticut, United States

DeepLook Medical is a developer of a medical imaging software.

Health CareMedicalSoftware
Series ASep 18, 2024
DeepLook Medical

New Haven, Connecticut, United States

DeepLook Medical is a developer of a medical imaging software.

Health CareMedicalSoftware
SeedFeb 8, 2024
Amount Raised: $1,700,000
iQure Pharma

Wilmington, Delaware, United States

iQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.

BiotechnologyPharmaceuticalTherapeutics
Series UnknownOct 11, 2023
Amount Raised: $1,200,000
Halitus

Berlin, Berlin, Germany

Early disease detection with a portable, simple-to-use device. Turning air into data. Mixed Hardware + SaaS

Health DiagnosticsInformation TechnologyMachine LearningMedical Device
Pre SeedJul 5, 2023
Amount Raised: $1,085,516